Evidence map›Paper›PMID 18457232›Full record

ReviewSleep2008

Pontine reticular formation (PnO) administration of hypocretin-1 increases PnO GABA levels and wakefulness.

Christopher J Watson, Haideliza Soto-Calderon, Ralph Lydic, Helen A Baghdoyan

Open access · bronzeAbstract readReview
In one paragraph

Review in Sleep, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 60 citations in OpenAlex.

  1. Article
  2. Article
  3. Consciousness loss during epileptogenesis: implication for VLPO-PnO circuits.International journal of physiology, pathophysiology and pharmacology · 2017
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Control of sleep and wakefulness.Physiological reviews · 2012
    Review
  15. Article
  16. Article
  17. Endogenous GABA levels in the pontine reticular formation are greater during wakefulness than during rapid eye movement sleep.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2011
    Article
  18. Neuropharmacology of Sleep and Wakefulness.Sleep medicine clinics · 2010
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Christopher J WatsonDepartment ofAnesthesiology, University ofMichigan, Ann Arbor, MI 48109-5615, USA.
Haideliza Soto-Calderon
Ralph Lydic
Helen A Baghdoyan
University of Michigan–Ann Arbor · US

Funding

CHOLINERGIC MECHANISMS OF REM SLEEP GENERATIONR37MH045361 · NIMH · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI BAGHDOYAN, HELEN A · 2004 to 2013
$3.4M
CHOLINERGIC MECHANISMS OF BREATHING DURING SLEEPR01HL040881 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LYDIC, RALPH · 1989 to 2010
$3.3M
CHOLINERGIC PHENOTYPE IN MURINE MODELS OF SLEEPR01HL065272 · NHLBI · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI LYDIC, RALPH · 1999 to 2013
$3.2M
OPIOID INDUCED REM SLEEP INHIBITIONR01HL057120 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LYDIC, RALPH · 1997 to 2005
$2.0M
CHOLINERGIC MECHANISMS OF REM SLEEP GENERATIONR01MH045361 · NIMH · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BAGHDOYAN, HELEN A · 1994 to 2003
$807k
CHOLINERGIC MECHANISMS OF REM SLEEP GENERATIONR29MH045361 · NIMH · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI BAGHDOYAN, HELEN A · 1989 to 1993
–
NHLBI NIH HHS HL40881NHLBI NIH HHS HL57120NHLBI NIH HHS HL65272NHLBI NIH HHS R01 HL040881NHLBI NIH HHS R01 HL057120NHLBI NIH HHS R01 HL065272NIMH NIH HHS MH45361NIMH NIH HHS R01 MH045361NIMH NIH HHS R37 MH045361
6 · The paper itself

Abstract

STUDY

objectivesGABAergic transmission in the oral part of the pontine reticular formation (PnO) increases wakefulness. The hypothalamic peptide hypocretin-1 (orexin A) promotes wakefulness, and the PnO receives hypocretinergic input. The present study tested the hypothesis that PnO administration of hypocretin-1 increases PnO GABA levels and increases wakefulness. This study also tested the hypothesis that wakefulness is either increased or decreased, respectively, by PnO administration of drugs known to selectively increase or decrease GABA levels.

designAwithin-subjects design was used for microdialysis and microinjection experiments.

settingUniversity of Michigan. PATIENTS OR

participantsExperiments were performed using adult male Crl:CD (SD)IGS BR (Sprague-Dawley) rats (n=46).

interventionsPnO administration of hypocretin-1, nipecotic acid (a GABA uptake inhibitor that increases extracellular GABA levels), 3-mercaptopropionic acid (a GABA synthesis inhibitor that decreases extracellular GABA levels; 3-MPA), and Ringer solution (vehicle control). MEASUREMENTS AND

resultsDialysis administration of hypocretin-1 to the PnO caused a statistically significant, concentration-dependent increase in PnO GABA levels. PnO microinjection of hypocretin-1 or nipecotic acid caused a significant increase in wakefulness and a significant decrease in non-rapid eye movement (NREM) sleep and REM sleep. Microinjecting 3-MPA into the PnO caused a significant increase in NREM sleep and REM sleep and a significant decrease in wakefulness.

conclusionsAn increase or a decrease in PnO GABA levels causes an increase or decrease, respectively, in wakefulness. Hypocretin-1 may promote wakefulness, at least in part, by increasing GABAergic transmission in the PnO.

Indexed as

AnimalsArousalBody Temperaturegamma-Aminobutyric AcidInjectionsIntracellular Signaling Peptides and ProteinsNeuropeptidesOrexinsPonsRatsRats, Sprague-DawleyReticular FormationSleep Initiation and Maintenance DisordersSleep, REMWakefulnessgamma-Aminobutyric AcidIntracellular Signaling Peptides and ProteinsNeuropeptidesOrexins

Identifiers

PMID18457232
PMCPMC2279760
OpenAlexW2099779245

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.